文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

单核细胞/淋巴细胞比值作为重症患者30天死亡与不良事件的预测指标:MIMIC-III数据库分析

[Monocyte/lymphocyte ratio as a predictor of 30-day mortality and adverse events in critically ill patients: analysis of the MIMIC-III database].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论MIMIC-III回顾性分析显示,ICU入科首日MLR≥0.5与30天死亡、CRRT、机械通气>5天、ICU住院>5天及总住院>14天独立相关,可用于重症患者风险分层。

该研究从MIMIC-III数据库提取43 174例重症患者资料,计算ICU入科首日单核细胞/淋巴细胞比值(MLR),用ROC曲线评估其对30天死亡的预测价值并确定cut-off值为0.5,据此分为高MLR组(16 948例)与低MLR组(26 226例)。高MLR组30天死亡率20.0% vs 低MLR组8.3%,CRRT比例3.6% vs 0.7%,机械通气>5天18.4% vs 5.7%,ICU住院>5天33.2% vs 20.4%,总住院>14天33.7% vs 16.2%,差异均有统计学意义(均P<0.05)。多因素Logistic回归校正相关因素后,MLR升高是30天死亡的独立危险因素(OR=1.54,95%CI 1.37-1.72,P<0.001),并与CRRT(OR=2.77,95%CI 2.18-3.51)、机械通气>5天(OR=2.45,95%CI 2.21-2.72)、ICU住院>5天(OR=2.29,95%CI 2.10-2.49)、总住院>14天(OR=2.28,95%CI 2.08-2.49)风险独立相关(均P<0.001)。作者认为MLR可用于重症患者风险分层。

要点

  • MLR预测30天死亡的AUC为0.655(95%CI 0.632-0.687),按最大约登指数确定cut-off值为0.5。
  • 高MLR组(≥0.5)30天死亡率20.0% vs 低MLR组(<0.5)8.3%,差异有统计学意义(P<0.05)。
  • 校正相关因素后,MLR升高是30天死亡的独立危险因素(OR=1.54,95%CI 1.37-1.72,P<0.001)。
  • MLR升高与CRRT(OR=2.77,95%CI 2.18-3.51)、机械通气>5天(OR=2.45,95%CI 2.21-2.72)、ICU住院>5天(OR=2.29,95%CI 2.10-2.49)、总住院>14天(OR=2.28,95%CI 2.08-2.49)独立相关(均P<0.001)。
  • 作者认为MLR可用于重症患者风险分层。

适用人群与场景

  • MIMIC-III数据库中的重症患者,共43 174例,纳入 demographics、血常规、生化、SIRS评分、SOFA评分及结局等资料。
  • 按ICU入科首日MLR cut-off值0.5分为高MLR组(16 948例,MLR≥0.5)和低MLR组(26 226例,MLR<0.5)。

诊断标准与关键阈值

  • MLR cut-off值为0.5,由ROC曲线按最大约登指数计算得出,用于预测30天死亡。

研究设计与关键结果

  • 研究类型为基于MIMIC-III数据库的回顾性分析,样本量43 174例重症患者,计算ICU入科首日MLR。
  • ROC曲线显示MLR预测30天死亡的AUC为0.655(95%CI 0.632-0.687),cut-off值0.5。
  • 高MLR组与低MLR组比较:年龄66.0(51.7,78.4)岁 vs 57.6(27.1,74.6)岁,男性比例57.2% vs 52.5%,BMI 26.5(22.5,31.1)kg/m² vs 24.7(14.3,29.7)kg/m²。
  • 高MLR组并发症发生率更高:高血压49.2% vs 44.6%,慢性心力衰竭32.6% vs 21.7%,糖尿病27.0% vs 23.4%,慢性阻塞性肺疾病21.5% vs 16.1%,肾功能不全19.3% vs 13.1%。
  • 高MLR组WBC 13.8(9.6,19.2)×10⁹/L vs 11.5(8.4,15.6)×10⁹/L,血糖8.66(6.88,11.49)mmol/L vs 8.27(6.55,10.88)mmol/L,乳酸2.2(1.5,3.7)mmol/L vs 2.1(1.4,3.3)mmol/L,血肌酐106.1(70.7,176.8)μmol/L vs 88.4(70.7,132.6)μmol/L,SIRS评分3(2,4) vs 2(2,3),SOFA评分4(2,7) vs 3(1,5)。
  • 高MLR组30天死亡率20.0% vs 8.3%,ICU住院>5天比例33.2% vs 20.4%,总住院>14天比例33.7% vs 16.2%,CRRT比例3.6% vs 0.7%,机械通气>5天比例18.4% vs 5.7%,差异均有统计学意义(均P<0.05)。
  • 多因素Logistic回归校正相关因素后,MLR升高是30天死亡的独立危险因素(OR=1.54,95%CI 1.37-1.72,P<0.001),并与CRRT(OR=2.77,95%CI 2.18-3.51)、机械通气>5天(OR=2.45,95%CI 2.21-2.72)、ICU住院>5天(OR=2.29,95%CI 2.10-2.49)、总住院>14天(OR=2.28,95%CI 2.08-2.49)风险独立相关(均P<0.001)。

证据类型、等级与局限

  • 证据类型:基于MIMIC-III数据库的回顾性分析,大样本。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为MLR可用于重症患者风险分层;MLR升高是30天死亡、CRRT使用、机械通气时间延长、住院时间延长及ICU住院时间延长的独立危险因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the correlation of monocyte/lymphocyte ratio (MLR) with the prognosis and adverse event in critically ill patients.

METHODS: Basic information of patients were extracted from Medical Information Mart for Intensive Care-III (MIMIC-III), including demographics, blood routine, biochemical indexes, systemic inflammatory response syndrome score (SIRS), sequential organ failure assessment (SOFA) score, and outcome, etc. MLR on the first day of intensive care unit (ICU) admission was calculated. The receiver operating characteristic curve (ROC curve) was applied to evaluate the prognostic value of MLR on the 30-day mortality and its cut-off value. According to the cut-off value, the patients were divided into two groups, and the differences between the groups were compared. Logistic regression model was used to analyze the relationship of MLR with 30-day mortality, continuous renal replacement therapy (CRRT), mechanical ventilation, the length of ICU stay, and total hospitalization time.

RESULTS: (1) A total of 43 174 critically ill patients were included. ROC curve showed that area under ROC curve (AUC) of MLR in predicting 30-day mortality was 0.655 [95% confidence interval (95%CI) was 0.632-0.687]. The cut-off value of MLR calculated according to the maximum Yoden index was 0.5. There were 16 948 patients with MLR ≥ 0.5 (high MLR group) and 26 226 patients with MLR < 0.5 (low MLR group). (2) Compared with the low MLR group, the high MLR group had higher age, proportion of male, body mass index (BMI) [age (years old): 66.0 (51.7, 78.4) vs. 57.6 (27.1, 74.6), proportion of male: 57.2% vs. 52.5%, BMI (kg/m2): 26.5 (22.5, 31.1) vs. 24.7 (14.3, 29.7)]. The high MLR group also had higher incidence of complications (hypertension: 49.2% vs. 44.6%, chronic heart failure: 32.6% vs. 21.7%, diabetes mellitus: 27.0% vs. 23.4%, chronic obstructive pulmonary disease: 21.5% vs. 16.1%, renal insufficiency: 19.3% vs. 13.1%), and higher white blood cell count (WBC), blood glucose, lactate (Lac), serum creatinine (SCr), SIRS score and SOFA score [WBC (×109/L): 13.8 (9.6, 19.2) vs. 11.5 (8.4, 15.6), blood glucose (mmol/L): 8.66 (6.88, 11.49) vs. 8.27 (6.55, 10.88), Lac (mmol/L): 2.2 (1.5, 3.7) vs. 2.1 (1.4, 3.3), SCr (μmol/L): 106.1 (70.7, 176.8) vs. 88.4 (70.7, 132.6), SIRS score: 3 (2, 4) vs. 2 (2, 3), SOFA score: 4 (2, 7) vs. 3 (1, 5)]. The 30-day mortality, and the proportion of patients with length of ICU stay > 5 days, total hospitalization time > 14 days, CRRT and mechanical ventilation > 5 days were significantly higher in high MLR group (30-day mortality: 20.0% vs. 8.3%, length of ICU stay > 5 days: 33.2% vs. 20.4%, total hospitalization time > 14 days: 33.7% vs. 16.2%, CRRT: 3.6% vs. 0.7%, mechanical ventilation > 5 days: 18.4% vs. 5.7%), with statistically significant differences (all P < 0.05). (3) After adjusted with the related factors, multivariate Logistic regression analysis showed that elevated MLR was an independent risk factor for increased 30-day mortality [odd ratio (OR) = 1.54, 95%CI was 1.37-1.72, P < 0.001]. Moreover, the increased MLR was independently associated with the increased risk of usage of CRRT (OR = 2.77, 95%CI was 2.18-3.51), mechanical ventilation > 5 days (OR = 2.45, 95%CI was 2.21-2.72), the length of ICU stay > 5 days (OR = 2.29, 95%CI was 2.10-2.49), and total hospitalization time > 14 days (OR = 2.28, 95%CI was 2.08-2.49), all P < 0.001.

CONCLUSIONS: Retrospective analysis of large sample shows that MLR elevation is an independent risk factor for 30-day mortality, usage of CRRT, prolonged mechanical ventilation time, prolonged hospitalization, prolonged length of ICU stay. MLR can be used for risk stratification of severe patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li Y, Liu Y, Zhou C, et al. [Monocyte/lymphocyte ratio as a predictor of 30-day mortality and adverse events in critically ill patients: analysis of the MIMIC-III database]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34112297. doi:10.3760/cma.j.cn121430-20201223-00772

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。